Related Experiment Video

Updated: Aug 23, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Cost-effectiveness in Preventive Cardiology

William S. Weintraub1

  • 1Division of Cardiology, Emory University School of Medicine, Emory Center for Outcomes Research, Briarcliff Campus, Atlanta, GA 30322, USA. wweintr@emory.edu

Current Treatment Options in Cardiovascular Medicine
|June 24, 2004
PubMed

Insights

Clinical efficacy is key for cardiovascular disease treatments. Cost-effectiveness analysis helps society make rational decisions about resource allocation for these interventions.

Area of Science:

  • Health economics
  • Cardiovascular medicine
  • Public health policy

Background:

  • Cardiovascular disease (CVD) poses significant risks, including mortality, disability, and high healthcare costs.
  • Clinical efficacy is the primary consideration for selecting CVD therapies.
  • Limited resources necessitate careful evaluation of healthcare interventions.

Purpose of the Study:

  • To highlight the importance of cost-effectiveness analysis in guiding medical decisions for cardiovascular disease.
  • To emphasize the role of economic evaluation alongside clinical efficacy.

Main Methods:

  • Review of cost-effectiveness analysis principles in healthcare decision-making.
  • Examination of data requirements and complexities in economic evaluations.
  • Assessment of the cost-effectiveness of cardiovascular disease prevention strategies.

Main Results:

  • Cost-effectiveness analysis is the optimal method for rational societal decision-making in medicine.
  • Effective cardiovascular disease prevention interventions are often cost-effective when priced reasonably.
  • Challenges exist due to complicated methods and suboptimal data in cost-effectiveness analyses.

Conclusions:

  • Cost-effectiveness analysis is crucial for responsible resource allocation in cardiovascular disease management.
  • Prioritizing clinically effective and reasonably priced interventions ensures better health outcomes.
  • Continued refinement of cost-effectiveness methodologies is needed for optimal healthcare planning.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...